These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8016474)

  • 1. Immunosuppressive drugs and their effects.
    Superdock KR; Helderman JH
    Semin Respir Infect; 1993 Sep; 8(3):152-9. PubMed ID: 8016474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunology in clinical practice. VI. Current immunosuppressive drugs].
    ten Berge RJ; Schellekens PT
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplant immunopharmacology: you can fool with mother nature!
    Vasquez EM; Westin ED
    Nurs Case Manag; 1999; 4(1):37-48. PubMed ID: 10232222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of different long-term maintenance immunosuppressive therapy strategies on patients' outcome after heart transplantation.
    Dandel M; Lehmkuhl HB; Knosalla C; Hetzer R
    Transpl Immunol; 2010 Jul; 23(3):93-103. PubMed ID: 20434559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal transplantation, past, present and future.
    Ponticelli C; Tarantino A; Vegeto A
    J Nephrol; 1999; 12 Suppl 2():S105-10. PubMed ID: 10688409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New immunosuppressive therapies in kidney transplantation].
    Pomer S
    Urologe A; 1994 Sep; 33(5):370-6. PubMed ID: 7974924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive agents in organ transplantation].
    Bergan S; Albrechtsen D; Bentdal O
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3615-20. PubMed ID: 10563181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspectives of immunosuppressive therapy].
    Meuer S; Sido B; Dengler T
    Chirurg; 1996 Apr; 67(4):310-7. PubMed ID: 8646915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.
    Cramer DV; Chapman FA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of immunosuppressive therapy in organ transplantation.
    MacGregor MS; Bradley JA
    Br J Hosp Med; 1995 Sep 20-Oct 3; 54(6):276-84. PubMed ID: 8542176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression in organ transplantation.
    Jordan SC; Rosenthal P; Makowka L
    Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the use of cyclosporine in renal transplantation.
    Yoshimura N; Okamoto M; Akioka K; Kaihara S
    Transplant Proc; 2004 Mar; 36(2 Suppl):181S-185S. PubMed ID: 15041333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive treatment: surveillance, toxicity, prospects].
    Giral M; Dantal J; Soulillou JP
    Rev Prat; 1994 Feb; 44(4):442-8. PubMed ID: 8184259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
    Reichenspurner H
    J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of cyclosporine on the development of immunosuppressive therapy.
    Haberal M; Emiroglu R; Dalgiç A; Karakayli H; Moray G; Bilgin N
    Transplant Proc; 2004 Mar; 36(2 Suppl):143S-147S. PubMed ID: 15041325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Graft immunity in lung transplantation].
    Mornex JF
    Rev Mal Respir; 2003 Apr; 20(2 Pt 1):257-66. PubMed ID: 12844023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunosuppressants on the expansion and function of naturally occurring regulatory T cells.
    Lim DG; Joe IY; Park YH; Chang SH; Wee YM; Han DJ; Kim SC
    Transpl Immunol; 2007 Nov; 18(2):94-100. PubMed ID: 18005851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.